Patient-reported outcome results from the open-label, randomized phase III myeloma X trial evaluating salvage autologous stem-cell transplantation in relapsed multiple myeloma

Autor: Ahmedzai, SH, Snowden, JA, Ashcroft, AJ, Cairns, DA, Williams, C, Hockaday, A, Cavenagh, JD, Ademokun, D, Tholouli, E, Allotey, D, Dhanapal, V, Jenner, M, Yong, K, Cavet, J, Hunter, H, Bird, JM, Pratt, G, Parrish, C, Brown, JM, Morris, TCM, Cook, G, NCRI Haemato-Oncology Clinical Studies Group

PURPOSE: Salvage autologous stem-cell transplantation (sASCT) in patients with multiple myeloma (MM) relapsing after a prior autologous stem-cell transplantation leads to increased remission duration and overall survival. We report a comprehensive st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8b892d65e9d01a166698b3f1e5ad0345

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.

Autor: Ahmedzai SH; 1 The University of Sheffield, Sheffield, United Kingdom., Snowden JA; 2 Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Ashcroft AJ; 3 Pinderfields Hospital, Mid-Yorks NHS Trust, Wakefield, United Kingdom., Cairns DA; 4 University of Leeds, Leeds, United Kingdom., Williams C; 5 Nottingham City Hospitals, Nottingham City, United Kingdom., Hockaday A; 4 University of Leeds, Leeds, United Kingdom., Cavenagh JD; 6 Barts Health NHS Trust and The London NHS Trust, London, United Kingdom., Ademokun D; 7 Ipswich Hospital NHS Trust, Ipswich, United Kingdom., Tholouli E; 8 Manchester Royal Infirmary, Manchester, United Kingdom., Allotey D; 9 Royal Derby Hospital, Derby, United Kingdom., Dhanapal V; 10 Medway Maritime Hospital, Gillingham, United Kingdom., Jenner M; 11 University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Yong K; 12 University College Hospital, London, United Kingdom., Cavet J; 13 The Christie NHS Foundation Trust, Manchester, United Kingdom., Hunter H; 14 Plymouth Hospitals Trust, Plymouth, United Kingdom., Bird JM; 15 University Hospitals Bristol NHS Trust, Bristol, United Kingdom., Pratt G; 16 University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Parrish C; 4 University of Leeds, Leeds, United Kingdom., Brown JM; 4 University of Leeds, Leeds, United Kingdom., Morris TCM; 17 Queen's University, Belfast, United Kingdom., Cook G; 4 University of Leeds, Leeds, United Kingdom.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Jul 01; Vol. 37 (19), pp. 1617-1628. Date of Electronic Publication: 2019 Apr 10.